{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:54:03Z","timestamp":1792004043402,"version":"4.4.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The aim of this study was to evaluate the short- and long-term outcome of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for hepatitis-related hepatocellular carcinoma (HCC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary Background Data:<\/jats:title>\n            <jats:p>ALPPS has been advocated for future liver remnant (FLR) augmentation in liver metastasis or noncirrhotic liver tumors in recent years. Data on the effect of ALPPS in chronic hepatitis or cirrhosis-related HCC remained scarce.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data for clinicopathological details, portal hemodynamics, and oncological outcome were reviewed for ALPPS and compared with portal vein embolization (PVE). Tumor immunohistochemistry for PD-1, VEGF, and AFP was evaluated in ALPPS and compared with PVE and upfront hepatectomy (UH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 2002 to 2018, 148 patients with HCC (hepatitis B: n = 136, 92.0%) underwent FLR modulation (ALPPS, n = 46; PVE: n = 102). One patient with ALPPS and 33 patients with PVE failed to proceed to resection (resection rate: 97.8% vs 67.7%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Among those who had resections, 65 patients (56.5%) had cirrhosis. ALPPS induced absolute FLR volume increment by 48.8%, or FLR estimated total liver volume ratio by 12.8% over 6 days. No difference in morbidity (20.7% vs 30.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.159) and mortality (6.5% vs 5.8%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 1.000) with PVE was observed. Chronic hepatitis and intraoperative indocyanine green clearance rate \u226439.5% favored adequate FLR hypertrophy in ALPPS. Five-year overall survival for ALPPS and PVE was 46.8% and 64.1% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.234). Tumor immunohistochemical staining showed no difference in expression of PD-1, V-EGF, and AFP between ALPPS, PVE, and UH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>ALPPS conferred a higher resection rate in hepatitis-related HCC with comparable short- and long-term oncological outcome with PVE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sla.0000000000003433","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T22:14:38Z","timestamp":1562883278000},"page":"957-965","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":119,"title":["ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma"],"prefix":"10.1097","volume":"273","author":[{"given":"Albert Chi-Yan","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"},{"name":"Department of Surgery, HKU-Shenzhen Hospital, The University of Hong Kong, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chok","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"},{"name":"Department of Surgery, HKU-Shenzhen Hospital, The University of Hong Kong, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Surgery, HKU-Shenzhen Hospital, The University of Hong Kong, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Kwan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"},{"name":"Department of Surgery, HKU-Shenzhen Hospital, The University of Hong Kong, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Poon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Mau","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China"},{"name":"Department of Surgery, HKU-Shenzhen Hospital, The University of Hong Kong, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/SLA.0b013e3181b674df","article-title":"Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry","volume":"250","author":"Kishi","year":"2009","journal-title":"Ann Surg"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1245\/s10434-012-2864-7","article-title":"Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases","volume":"20","author":"Shindoh","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/SLA.0b013e318248577d","article-title":"Playing Play-Doh to prevent postoperative liver failure: the \u201cALPPS\u201d approach","volume":"255","author":"de Santibanes","year":"2012","journal-title":"Ann Surg"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SLA.0000000000000947","article-title":"Early survival and safety of ALPPS: first report of the International ALPPS Registry","volume":"260","author":"Schadde","year":"2014","journal-title":"Ann Surg"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/SLA.0000000000002446","article-title":"Risk adjustment in ALPPS is associated with a dramatic decrease in early mortality and morbidity","volume":"266","author":"Linecker","year":"2017","journal-title":"Ann Surg"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/SLA.0000000000001046","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center","volume":"261","author":"Alvarez","year":"2015","journal-title":"Ann Surg"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","article-title":"ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)","volume":"267","author":"Sandstrom","year":"2018","journal-title":"Ann Surg"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/SLA.0000000000001633","article-title":"ALPPS\u2014where do we stand, where do we go?: eight recommendations from the first international expert meeting","volume":"263","author":"Oldhafer","year":"2016","journal-title":"Ann Surg"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/SLA.0000000000002604","article-title":"Pushing the envelope in perihiler cholangiocellularcarcinoma surgery: TIPE-ALPPS","volume":"267","author":"Balci","year":"2018","journal-title":"Ann Surg"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SLA.0000000000002797","article-title":"10th anniversary of ALPPS-lessons learned and quo vadis","volume":"269","author":"Lang","year":"2018","journal-title":"Ann Surg"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00000658-199808000-00010","article-title":"Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization","volume":"228","author":"Goto","year":"1998","journal-title":"Ann Surg"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11605-009-1085-2","article-title":"Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection","volume":"14","author":"de Graaf","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1097\/SLA.0000000000000736","article-title":"Simplifying the ALPPS procedure by the anterior approach","volume":"260","author":"Chan","year":"2014","journal-title":"Ann Surg"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00268-015-3174-6","article-title":"Modified anterior approach for the ALPPS procedure: how we do it","volume":"39","author":"Chan","year":"2015","journal-title":"World J Surg"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/SLA.0000000000000213","article-title":"Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use?","volume":"258","author":"Ribero","year":"2013","journal-title":"Ann Surg"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0033-1356364","article-title":"Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre","volume":"52","author":"Nadalin","year":"2014","journal-title":"Z Gastroenterol"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1007\/s00464-015-4666-z","article-title":"Incidence, risk factors and consequences of bile leakage following laparoscopic major hepatectomy","volume":"30","author":"Cauchy","year":"2016","journal-title":"Surg Endosc"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11605-017-3650-4","article-title":"Clinical factors and postoperative impact of bile leak after liver resection","volume":"22","author":"Martin","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11605-018-3697-x","article-title":"ALPPS for hepatocellular carcinoma is associated with decreased liver remnant growth","volume":"22","author":"Chia","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/SLA.0b013e3181ffb2d7","article-title":"Decompression of the portal bed and twice-baseline portal inflow are necessary for the functional recovery of a \u201csmall-for-size\u201d graft","volume":"253","author":"Hessheimer","year":"2011","journal-title":"Ann Surg"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/lt.21989","article-title":"Portal hyperperfusion: mechanism of injury and stimulus for regeneration in porcine small-for-size transplantation","volume":"16","author":"Fondevila","year":"2010","journal-title":"Liver Transpl"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/TP.0b013e318181e02d","article-title":"Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft","volume":"86","author":"Umeda","year":"2008","journal-title":"Transplantation"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/j.1600-6143.2005.01081.x","article-title":"Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications","volume":"5","author":"Dahm","year":"2005","journal-title":"Am J Transplant"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/SLA.0000000000000949","article-title":"ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration","volume":"260","author":"Schlegel","year":"2014","journal-title":"Ann Surg"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.SLA.0000055277.78876.B7","article-title":"Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?","volume":"237","author":"Troisi","year":"2003","journal-title":"Ann Surg"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMp1401875","article-title":"Abolishing mammography screening programs? A view from the Swiss Medical Board","volume":"370","author":"Biller-Andorno","year":"2014","journal-title":"N Engl J Med"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/bjs.10978","article-title":"Mitochondrial function after associating liver partition and portal vein ligation for staged hepatectomy in an experimental model","volume":"106","author":"Budai","year":"2019","journal-title":"Br J Surg"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3748\/wjg.v24.i10.1107","article-title":"Maturity of associating liver partition and portal vein ligation for staged hepatectomy-derived liver regeneration in a rat model","volume":"24","author":"Tong","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.surg.2015.12.004","article-title":"Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization","volume":"159","author":"Matsuo","year":"2016","journal-title":"Surgery"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/1996\/62057","article-title":"Changes in hepatic hemodynamics due to primary liver tumours","volume":"9","author":"Jakab","year":"1996","journal-title":"HPB Surg"},{"key":"R32-20250618","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042737-200202000-00011","article-title":"Hepatic arterial blood flow in large hepatocellular carcinoma with or without portal vein thrombosis: assessment by transcutaneous duplex Doppler sonography","volume":"14","author":"Saftoiu","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.20279","article-title":"High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations","volume":"112","author":"Peng","year":"2004","journal-title":"Int J Cancer"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4143\/crt.2016.066","article-title":"Overexpression of PD-L1 and PD-L2 is associated with poor prognosis in patients with hepatocellular carcinoma","volume":"49","author":"Jung","year":"2017","journal-title":"Cancer Res Treat"},{"key":"R35-20250618","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2006.01.008","article-title":"Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma","volume":"242","author":"Pang","year":"2006","journal-title":"Cancer Lett"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jhep.2008.07.022","article-title":"siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo","volume":"49","author":"Raskopf","year":"2008","journal-title":"J Hepatol"},{"key":"R37-20250618","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2342031996","article-title":"Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients","volume":"234","author":"Di Stefano","year":"2005","journal-title":"Radiology"},{"key":"R38-20250618","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000184735","article-title":"Controversies in the use of portal vein embolization","volume":"25","author":"van Gulik","year":"2008","journal-title":"Dig Surg"},{"key":"R39-20250618","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhep.2014.09.002","article-title":"Reply to: \u201cALPPS procedure for hepatocellular carcinoma with macrovascular thrombosis: a new opportunity?\u201d","volume":"62","author":"Kokudo","year":"2015","journal-title":"J Hepatol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000003433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:03:20Z","timestamp":1750223000000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000003433"}},"subtitle":["A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy"],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000003433","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]}}}